Search - tctmd.com

Displaying 41 - 60 of 147

Sort: Relevancy | Date

News Daily News

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

August 11, 2015

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

Study Explores Safety of Early Discharge After Transfemoral TAVR

L.A. McKeown

June 24, 2015

News Industry News

Bradycardia Patients Test Drive Pacemakers

June 24, 2015

News Daily News

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

L.A. McKeown

June 17, 2015

News Daily News

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Yael L. Maxwell

June 03, 2015

News Conference News EuroPCR 2015

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Yael L. Maxwell

May 22, 2015

News Conference News EuroPCR 2015

Sapien 3 Experience in Europe, Canada Shows Low Mortality, Paravalvular Leak at 30 Days

Yael L. Maxwell

May 21, 2015

News Daily News

无引线起搏器在置入后 1 年间表现良好

Yael L. Maxwell

April 29, 2015

News Daily News

Leadless Pacemaker Performs Well Through 1 Year

Yael L. Maxwell

April 29, 2015

News Daily News

Buen Funcionamiento al cabo de 1 Año de un Marcapasos Sin Electrodos

Yael L. Maxwell

April 29, 2015

News Daily News

As TAVR Evolves, Local Anesthesia Could Be an Option for Lower-Risk Patients

Yael L. Maxwell

April 03, 2015

News Conference News ACC 2015

DEFLECT III: TAVR Neuroprotection Device Safely Reduces Lesion Volume

Yael L. Maxwell

March 16, 2015

News Conference News ACC 2015

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

Yael L. Maxwell

March 15, 2015

News Daily News

Un Análisis del PARTNER Analiza los Predictores e Impacto Clínico de la Implantación de Marcapasos

January 28, 2015

News Daily News

PARTNER 分析揭示起搏器置入的预测因素和临床影响

January 28, 2015

Advertisement

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

Study Explores Safety of Early Discharge After Transfemoral TAVR

Bradycardia Patients Test Drive Pacemakers

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Sapien 3 Experience in Europe, Canada Shows Low Mortality, Paravalvular Leak at 30 Days

无引线起搏器在置入后 1 年间表现良好

Leadless Pacemaker Performs Well Through 1 Year

Buen Funcionamiento al cabo de 1 Año de un Marcapasos Sin Electrodos

As TAVR Evolves, Local Anesthesia Could Be an Option for Lower-Risk Patients

DEFLECT III: TAVR Neuroprotection Device Safely Reduces Lesion Volume

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

Un Análisis del PARTNER Analiza los Predictores e Impacto Clínico de la Implantación de Marcapasos

PARTNER 分析揭示起搏器置入的预测因素和临床影响

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content